Theravance Biopharma, Inc. (TBPH)

NASDAQ: TBPH · Real-Time Price · USD

13.81

-0.22 (-1.57%)

At close: Mar 11, 2026, 4:00 PM EDT

13.80

-0.01 (-0.07%)

After-hours: Mar 11, 2026, 4:10 PM EDT

Theravance Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	80.33	64.38	57.42	51.35	55.31	71.86
Revenue Growth (YoY)	27.12%	12.12%	11.84%	-7.17%	-23.03%	-2.12%
Gross Profit	80.33	64.38	57.42	51.35	55.31	71.86
Selling, General & Admin	73.63	69.17	70.1	67.07	99.3	108.53
Research & Development	39.51	37.64	40.62	63.39	193.66	260.95
Other Operating Expenses	-	4.51	2.74	12.84	20.14	-
Total Operating Expenses	113.14	111.33	113.46	143.3	313.1	369.48
Operating Income	-32.81	-46.95	-56.04	-91.96	-257.78	-297.63
Interest Income	82.58	4.88	9.12	8.55	1.11	2.83
Interest Expense	-2.52	-2.55	-2.35	-6.37	-8.55	-8.55
Other Non-Operating Income (Expense)	-	-	-	-3.03	-	-
Total Non-Operating Income (Expense)	80.05	2.34	6.77	-0.86	-7.44	-5.72
Pretax Income	47.24	-44.61	-49.27	-92.82	-265.22	-303.34
Provision for Income Taxes	-32.02	-11.8	-5.92	-178.98	-0.15	-8.52
Net Income	29.34	-56.42	-55.19	872.13	-199.43	-278.02
Earnings From Discontinued Operations	-	-	-	964.96	65.65	16.81
Net Income to Common	29.34	-56.42	-55.19	872.13	-199.43	-278.02
Shares Outstanding (Basic)	50	49	55	74	69	62
Shares Outstanding (Diluted)	50	49	55	74	69	62
Shares Change (YoY)	3.15%	-11.67%	-24.85%	5.95%	11.41%	10.50%
EPS (Basic)	0.58	-1.15	-1.00	11.85	-2.87	-4.46
EPS (Diluted)	0.57	-1.15	-1.00	11.85	-2.87	-4.46
Free Cash Flow	243.48	-11.87	-29.49	-187.56	-211.26	-257.02
Free Cash Flow Per Share	4.83	-0.24	-0.53	-2.55	-3.04	-4.12
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-40.85%	-72.92%	-97.58%	-179.09%	-466.06%	-414.19%
Profit Margin	-36.24%	-87.63%	-96.11%	-180.78%	-479.24%	-410.29%
FCF Margin	303.11%	-18.43%	-51.35%	-365.29%	-381.96%	-357.68%
EBITDA	-31.17	-45.24	-54.03	-88.24	-252.98	-292.92
EBITDA Margin	-38.80%	-70.27%	-94.10%	-171.86%	-457.38%	-407.64%
EBIT	-32.81	-46.95	-56.04	-91.96	-257.78	-297.63
EBIT Margin	-40.85%	-72.92%	-97.58%	-179.09%	-466.06%	-414.19%
Effective Tax Rate	138.75%	26.46%	12.02%	192.84%	0.06%	2.81%

Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q